Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly
Authors:
- 1 April 2010
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 27 (4) , 327-335
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Longitudinal study of muscle strength, quality, and adipose tissue infiltrationThe American Journal of Clinical Nutrition, 2009
- Pain in patients living in Norwegian nursing homesPalliative Medicine, 2008
- A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer painBMC Palliative Care, 2008
- Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)Pain Practice, 2008
- Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration studyInternational Journal Of Clinical Practice, 2007
- Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO‑127)Current Medical Research and Opinion, 2007
- Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe painClinical Therapeutics, 2006
- Effects of dementia on perceived daily pain in home-dwelling elderly people: a population-based studyAge and Ageing, 2004
- An Epidemiologic Analysis of Pain in the ElderlyJournal of Aging and Health, 1994
- An epidemiologic comparison of pain complaintsPain, 1988